BioSpherix
Develops cytocentric laboratory equipment (precision gas controllers, incubator subchambers, Xvivo System) for controlling in-vitro and in-vivo environments, enabling contamination-free bioprinting workflows.
- CEO / Founder
- Syed Ahmed Mustafa
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $350K
- Latest Round
- Grant
- Key Investors
- CNYBAC, Contained Air Solutions Ltd
Technology & Products
Key Products
Xvivo System®; ProOx C21 Oxygen and Carbon Dioxide Controller; C-Chamber incubator subchambers; Precision gas controllers
Technological Advantage
Proprietary closed-system technology protected by US and international patents (e.g., for 'Aseptic Cell Processing and Production with No Chemical Biocides'); enables integration with bioprinters of any dimension for contamination-free workflows.
Differentiation
Value Proposition
Provides closed-system, self-sanitizing environments that maintain sterile conditions and precise physiological parameters (O₂, CO₂, temperature, humidity) during bioprinting and cell culture, reducing contamination risks and ensuring batch compliance for advanced cell therapies.
How They Differentiate
Unlike standard incubator manufacturers, BioSpherix offers closed-system, modular cytocentric environments specifically designed to integrate with bioprinters and control physiological parameters during printing, reducing contamination risks vs. open cleanroom setups.
Market & Competition
Target Customers
Academic/research institutions, pharmaceutical/biotechnology companies, GMP cell manufacturing facilities
Industry Verticals
Biotechnology; Pharmaceutical; Regenerative Medicine; Cell & Gene Therapy
Competitors
Buffalo BioLabs, Seed Therapeutics, KSL Diagnostics
Growth & Milestones
Growth Metrics
Revenue estimated $6.7M annually; 35-43 employees; establishing BioSpherix Center for Cytocentric Technology in Winston-Salem, NC with NSF grant support.
Major Milestones
Founded in 1982; Established BioSpherix Medical in 2014; NSF grant for regenerative medicine center in 2024; Strategic partnership with Cellbox Solutions; Manufacturing partnership with Minovia Therapeutics
Notable Customers
Bristol-Myers Squibb; Academic/research institutions worldwide